What's New?

Updated HHS Perinatal Antiretroviral Treatment Guidelines Released
Highlights:  More cART regimens for initial treatment of ARV-naïve pregnant women;  4 weeks of ZDV for infants of cART-adherent women with consistent viral suppression;  Intrapartum IV ZDV not recommended for women with viral load <1,000;  CD4 ct monitoring at 6-month intervals in women with viral suppression;  Periconception use of PrEP for HIV-uninfected partners may reduce risk of sexual HIV transmission

Training Spotlight

Check out our Clinical Cases in HIV Medical Care:  A Webinar Series!

The "Graying" of HIV Among Women 
Bill Short, MD
Thursday, April 17, 2014

Transgender Women, Hormone Therapy and HIV
Tonia Poteat, PhD, MPH, PA-C
Thursday, May 22, 2014

HIV and Dermatological Issues
Toby Maurer, MD
Thursday, July 3, 2014

Get the latest from SEATEC - follow us on social media